Literature DB >> 32938527

SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China.

Vanessa R Barrs, Malik Peiris, Karina W S Tam, Pierra Y T Law, Christopher J Brackman, Esther M W To, Veronica Y T Yu, Daniel K W Chu, Ranawaka A P M Perera, Thomas H C Sit.   

Abstract

We tested 50 cats from coronavirus disease households or close contacts in Hong Kong, China, for severe acute respiratory syndrome coronavirus 2 RNA in respiratory and fecal samples. We found 6 cases of apparent human-to-feline transmission involving healthy cats. Virus genomes sequenced from 1 cat and its owner were identical.

Entities:  

Keywords:  COVID-19; China; Hong Kong; SARS-CoV-2; close contacts; coronavirus; coronavirus disease; domestic cats; households; pandemic; quarantine; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Year:  2020        PMID: 32938527      PMCID: PMC7706951          DOI: 10.3201/eid2612.202786

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Naturally occurring human-to-animal transmission of severe acute respiratory syndrome (SARS) coronavirus was reported during 2003 when viral RNA was detected in oropharyngeal and rectal swab specimens from healthy domestic cats in a housing estate at the center of a large SARS cluster in Hong Kong, China; infections were confirmed serologically (). Susceptibility of cats to infection with this virus and transmission between cats were demonstrated experimentally (). Pulmonary pathologic changes, similar to those for humans with SARS, developed in infected cats, but the cats remained asymptomatic (,). These findings informed the current precautionary strategy of the Agriculture, Fisheries and Conservation Department of Hong Kong to quarantine mammalian pets from households with confirmed human coronavirus disease (COVID-19) or their close contacts (defined as a person who had face-to-face contact for >15 min with a person who had confirmed SARS coronavirus 2 [SARS-CoV-2] infection) in a holding facility, when alternative care was unavailable. Pets are swabbed for SARS-CoV-2 testing and confined until reverse transcription PCR (RT-PCR) results are negative on 2 consecutive occasions. Findings for 2 infected dogs have been reported (). We report testing results for cats. Swab (nasal, oral, rectal) specimens and feces collected from nonsedated cats after admission were tested for SARS-CoV-2 RNA at the Agriculture, Fisheries and Conservation Department Veterinary Laboratory by using a commercial RT-PCR targeting the partial envelope and RNA-dependent RNA polymerase genes (Molbiol Lightmix; TIB MOLBIOL, https://www.tib-molbiol.com). This PCR does not show cross-reactivity with these genes from enteric coronavirus (). For samples with positive or equivocal results, confirmatory quantitative RT-PCRs targeting nonstructural protein 4, nonstructural protein 16, nucleoprotein, and membrane genes were performed at the World Health Organization COVID-19 Reference Laboratory at the University of Hong Kong (). Animals with positive results were evaluated by repeated sampling to monitor viral shedding by RT-PCR. Serologic analysis was used selectively. We sampled 50 cats during February 11–August 11, 2020. Time from onset of COVID-19 symptoms in owners to first sampling of their cats was available for 21 owners of 35 cats and ranged from 3 to 15 (median 8, interquartile range 4) days. SARS-CoV-2 RNA was detected in samples from 6 (12%) of 50 cats (Table, https://wwwnc.cdc.gov/EID/article/26/12/20-2786-T1.htm). The first positive case (cat 1) was from a household that had 3 persons with confirmed cases of COVID-19; their symptoms (fever, cough, or shortness of breath) started on March 20, 29, and 30, 2020. Their 7-year old, female, domestic shorthair cat was examined by a veterinarian at admission on day 1 (March 30), and reported to be clinically healthy. Nasal, oral, and rectal swab specimens collected on day 1 were positive for SARS-CoV-2 RNA; viral nucleoprotein gene copy number were log10 6.3/mL, log10 5.6/mL, and 3.2 log10/mL, respectively. Attempts to culture virus from day 1 samples on Vero E6 (ATCC CRL-1586) cells as described () were unsuccessful. Viral RNA was detected in oral swab specimens for 8 days and nasal swab specimens for 11 days, but rectal swab specimens were negative after day 1 (Table).
Table

Results of reverse transcription PCR for detection of severe acute respiratory syndrome coronavirus 2 in nasal, oral, rectal, and fecal swab specimens for 6 cats, Hong Kong, China, 2020*

Animal breed/age, y/sex
Date tested
E gene, cutoff <36
RdRP gene, cutoff <40
NSP14 gene, cutoff <40
NP gene, cutoff <40
NSP16 gene, cutoff <40
M gene
N
O
R
Fe
N
O
R
Fe
N
O
R
Fe
N
O
R
Fe
N
O
R
Fe
N
O
R
Fe
DSH/7/FMar 30 21.3 22.9 33.0 ND 32.0 32.0 38.9 ND 26.8 29.6 38.0 ND 26.4 29.3 38.0 ND 27.4 32.3 38.9 ND 26.0 28.8 36.9 ND
Apr 1 35.5 26.7 NegND Neg 35.5 NegNDNeg 30.6 NegNDNeg 31.7 NegNDNeg 30.5 NegND 38.6 29.6 NegND
Apr 3 37.3 37.1 NegNDNegNegNegNDNegNegNegND 39.9 NegNegNDNegNegNegNDNegNegNegND
Apr 6Neg 35.9 NegNegNegNegNegNegNDNegNDNDNDNegNDNDNDNegNDNDNDNegNDND
Apr 9 38.6 NegNegNegNegNegNegNeg 38.4 NDNDNDNegNDNDNDNegNDNDNDNegNDNDND
Apr 14NegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNegNeg

Apr 15
Neg
Neg
Neg
ND

Neg
Neg
Neg
ND

Neg
Neg
Neg
ND

Neg
Neg
Neg
ND

Neg
Neg
Neg
ND

Neg
Neg
Neg
ND
DSH/3/MJul 13NegNegNeg 37.2 NegNegNegNegNDNDNDNegNDNDND 37.2 NDNDND 40.0 NDNDND 39.0
Jul 14NegNegNegNDNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Jul 15Neg 37.3 Neg 36.2 NegNegNegNegNDNegNDNegNDNegNDNegNDNegNDNegNDNegNDNeg
Jul 17NDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Jul 20NegNegNegNDNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Jul 21NDNDNDNegNDNDNDNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Jul 23NegNegNegNDNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND

Jul 24
ND
ND
ND
Neg

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND
ASH/13/MJul 21Neg 22.0 NegNDNeg 27.3 NegNDNeg 31.0 NegNDNeg 30.7 NegNDND 31.6 NDNDND 30.3 NDND
Jul 24Neg 29.0 NegNDNeg 34.9 NegNDND 34.7 NDNDND 34.9 NDNDNDNDNDNDNDNDNDND
Jul 27NDNDNDNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Jul 30NegNegNegNegNegNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND

Aug 4
Neg
Neg
Neg
ND

Neg
Neg
Neg
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND
DSH/2/FJul 28NegNeg 34.2 32.7 NegNeg 39.5 34.5 NDND 36.4 35.5 NDND 37.5 36.9 NDNDNDNDNDNDNDND
Aug 4NegNegNegNegNegNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND

Aug 7
Neg
Neg
Neg
Neg

Neg
Neg
Neg
Neg

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND
SSH/5/MJul 31Neg 26.8 NegNegNeg 33.1 NegNegNeg 32.7 NegNDNeg 29.7 NegNDNDNDNDNDNDNDNDND
Aug 4 34.6 35.3 36.5 32.7 40.0 NegNeg 37.4 NegNegNeg 37.0 37.3 37.9 Neg 34.1 NDNDNDNDNDNDNDND

Aug 11
Neg
Neg
Neg
Neg

Neg
Neg
Neg
Neg

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND

ND
ND
ND
ND
DSH/5/FAug 4Neg 36.0 NegNDND 40.0 NDNDND 37.2 NDNDNDNegNDNDNDNDNDNDNDNDNDND
Aug 11NegNegNegNegNegNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
Aug 13NegNegNegNDNegNegNegNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND

*Values are cycle thresholds. Values in bold are positive or equivocal results greater than the cutoff value. ASH, American shorthair; DSH, domestic shorthair; E, envelope; Fe, fecal; N, nasal; Neg negative; ND, not determined; NP, nucleoprotein; NSP, nonstructural protein; O, oral; R, rectal; rectal; RdRp, RNA-dependent RNA polymerase; SSH, Scottish shorthair.

*Values are cycle thresholds. Values in bold are positive or equivocal results greater than the cutoff value. ASH, American shorthair; DSH, domestic shorthair; E, envelope; Fe, fecal; N, nasal; Neg negative; ND, not determined; NP, nucleoprotein; NSP, nonstructural protein; O, oral; R, rectal; rectal; RdRp, RNA-dependent RNA polymerase; SSH, Scottish shorthair. We performed serologic analysis to detect neutralizing antibodies by using a 90% plaque reduction neutralization test for SARS-CoV-2 (). The result was positive for the only serum sample collected (on day 19) and had titer >1:320 (). Viral genomes from cat 1 and 1 owner were sequenced by using a MiSeq Sequencing Platform (Illumina, https://www.illumina.com) after reverse transcription of viral RNA and multiple, overlapping, »2-kb PCRs that targeted the viral genome (). Both genome sequences (29,830 nt sequenced; 99.8% of the genome) were identical (Figure) and deposited in GenBank (accession no. MT628701).
Figure

Phylogenetic analysis of SARS-CoV-2 full genome from an infected cat and the human index case-patient, Hong Kong, China. A virus sequenced directly from a tiger in a zoo in United States was included in this analysis. Virus genome alignment was prepared and manually trimmed at genome 5¢ and 3¢ ends for low-alignment quality. A resulting alignment of 29,655 nt was analyzed by using PhyML (http://www.atgc-montpellier.fr) and the generalized time reversible nucleotide substitution model. Branch support identified by using the fast approximate likelihood ratio test are shown at major nodes. The Hong Kong feline virus from cat 1 and that of its owner are shown in red. Canine and human viruses from Hong Kong, including from the dogs’ owners (HK_case 163 and HK_case 85) are shown in blue. Numbers along branches are bootstrap values. Scale bar indicates nucleotide substitutions per site. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Phylogenetic analysis of SARS-CoV-2 full genome from an infected cat and the human index case-patient, Hong Kong, China. A virus sequenced directly from a tiger in a zoo in United States was included in this analysis. Virus genome alignment was prepared and manually trimmed at genome 5¢ and 3¢ ends for low-alignment quality. A resulting alignment of 29,655 nt was analyzed by using PhyML (http://www.atgc-montpellier.fr) and the generalized time reversible nucleotide substitution model. Branch support identified by using the fast approximate likelihood ratio test are shown at major nodes. The Hong Kong feline virus from cat 1 and that of its owner are shown in red. Canine and human viruses from Hong Kong, including from the dogs’ owners (HK_case 163 and HK_case 85) are shown in blue. Numbers along branches are bootstrap values. Scale bar indicates nucleotide substitutions per site. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Four of the other 5 positive cats were from confirmed COVID-19infected households, and 1 indoor-only cat belonged to a close contact who was not confirmed to be infected. Time from onset of COVID-19 symptoms in owners to animal sampling was known for 3 cats (5, 11, and 8 days); 1 had equivocal envelope gene PCR results but was positive by a novel surrogate virus neutralization test (). Signs of disease did not develop in any infected cats, consistent with experimental feline infections, which are also usually subclinical (; A. Bosco-Lauth et al., unpub. data). COVID-19–like signs have been reported in domestic cats naturally infected with SARS-CoV-2 in other countries (). In addition, 4 tigers and 3 lions with respiratory signs in a zoo in New York, New York, USA, were confirmed to be shedding SARS-CoV-2 in feces (S.L. Bartlett et al., unpub. data). Susceptibility to SARS-CoV-2 might differ between felid species. SARS-CoV-2 RNA persisted longest in nasal secretions in 1 case for 11 days at low levels. Viral RNA was detected in nasal washes from kittens experimentally inoculated with SARS-CoV-2 for 8–9 days, after which sampling was stopped (). Cats acquiring infection from being cohoused with experimentally infected cats shed virus in respiratory secretions longer (7 days) than directly inoculated cats (5 days) (). Although feline-to-human transmission is theoretically possible, we did not find any evidence of this transmission. The timeline of infection in cat 1 and the finding of an identical SARS-CoV-2 genome sequence in a human from the same household is consistent with human-to-animal transmission. In support of these findings, the cat had no outdoor access. More widespread serologic surveillance of cats in contact with COVID-19 patients is warranted to determine the prevalence of human-to-cat transmission. Some infected cats might have stopped shedding virus before being quarantined because viral shedding periods as short as 3 days have been reported in experimentally infected cats ().
  6 in total

1.  A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.

Authors:  Chee Wah Tan; Wan Ni Chia; Xijian Qin; Pei Liu; Mark I-C Chen; Charles Tiu; Zhiliang Hu; Vivian Chih-Wei Chen; Barnaby E Young; Wan Rong Sia; Yee-Joo Tan; Randy Foo; Yongxiang Yi; David C Lye; Danielle E Anderson; Lin-Fa Wang
Journal:  Nat Biotechnol       Date:  2020-07-23       Impact factor: 54.908

2.  Pathology of experimental SARS coronavirus infection in cats and ferrets.

Authors:  J M A van den Brand; B L Haagmans; L Leijten; D van Riel; B E E Martina; A D M E Osterhaus; T Kuiken
Journal:  Vet Pathol       Date:  2008-07       Impact factor: 2.221

3.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Authors:  Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten
Journal:  Euro Surveill       Date:  2020-01

4.  Infection of dogs with SARS-CoV-2.

Authors:  Thomas H C Sit; Christopher J Brackman; Sin Ming Ip; Karina W S Tam; Pierra Y T Law; Esther M W To; Veronica Y T Yu; Leslie D Sims; Dominic N C Tsang; Daniel K W Chu; Ranawaka A P M Perera; Leo L M Poon; Malik Peiris
Journal:  Nature       Date:  2020-05-14       Impact factor: 49.962

5.  Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.

Authors:  Jianzhong Shi; Zhiyuan Wen; Gongxun Zhong; Huanliang Yang; Chong Wang; Baoying Huang; Renqiang Liu; Xijun He; Lei Shuai; Ziruo Sun; Yubo Zhao; Peipei Liu; Libin Liang; Pengfei Cui; Jinliang Wang; Xianfeng Zhang; Yuntao Guan; Wenjie Tan; Guizhen Wu; Hualan Chen; Zhigao Bu
Journal:  Science       Date:  2020-04-08       Impact factor: 47.728

6.  Virology: SARS virus infection of cats and ferrets.

Authors:  Byron E E Martina; Bart L Haagmans; Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Geert Van Amerongen; J S Malik Peiris; Wilina Lim; Albert D M E Osterhaus
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

  6 in total
  56 in total

Review 1.  SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study.

Authors:  Tessa Prince; Shirley L Smith; Alan D Radford; Tom Solomon; Grant L Hughes; Edward I Patterson
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

2.  Natural Transmission and Experimental Models of SARS CoV-2 Infection in Animals.

Authors:  Jessica C Gomes Noll; Gabriela M do Nascimento; Diego G Diel
Journal:  Comp Med       Date:  2021-10-26       Impact factor: 0.982

3.  Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.

Authors:  Ranawaka A P M Perera; Ronald Ko; Owen T Y Tsang; David S C Hui; Mike Y M Kwan; Christopher J Brackman; Esther M W To; Hui-Ling Yen; Kathy Leung; Samuel M S Cheng; Kin Ho Chan; Karl C K Chan; Ka-Chi Li; Linda Saif; Vanessa R Barrs; Joseph T Wu; Thomas H C Sit; Leo L M Poon; Malik Peiris
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 4.  Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach.

Authors:  Francisco Rodríguez-Frías; Josep Quer; David Tabernero; Maria Francesca Cortese; Selene Garcia-Garcia; Ariadna Rando-Segura; Tomas Pumarola
Journal:  Microorganisms       Date:  2021-12-06

Review 5.  Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals.

Authors:  David A Meekins; Natasha N Gaudreault; Juergen A Richt
Journal:  Viruses       Date:  2021-10-04       Impact factor: 5.048

6.  No molecular evidence of SARS-CoV-2 infection in companion animals from Veracruz, Mexico.

Authors:  Sokani Sánchez-Montes; Gerardo G Ballados-González; Janete Gamboa-Prieto; Anabel Cruz-Romero; Dora Romero-Salas; Carlos D Pérez-Brígido; María J Austria-Ruíz; Alfredo Guerrero-Reyes; Miguel A Lammoglia-Villagómez; Ireri P Camacho-Peralta; José Á Morales-Narcia; José L Bravo-Ramos; Manuel Barrientos-Villeda; Leopoldo A Blanco-Velasco; Ingeborg Becker
Journal:  Transbound Emerg Dis       Date:  2021-06-02       Impact factor: 4.521

7.  SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA.

Authors:  Sarah A Hamer; Alex Pauvolid-Corrêa; Italo B Zecca; Edward Davila; Lisa D Auckland; Christopher M Roundy; Wendy Tang; Mia Kim Torchetti; Mary Lea Killian; Melinda Jenkins-Moore; Katie Mozingo; Yao Akpalu; Ria R Ghai; Jessica R Spengler; Casey Barton Behravesh; Rebecca S B Fischer; Gabriel L Hamer
Journal:  Viruses       Date:  2021-05-19       Impact factor: 5.048

8.  Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.

Authors:  Mythili Dileepan; Da Di; Qinfeng Huang; Shamim Ahmed; Daniel Heinrich; Hinh Ly; Yuying Liang
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 9.  Animal models of SARS-CoV-2 transmission.

Authors:  Rory D de Vries; Barry Rockx; Bart L Haagmans; Sander Herfst; Marion Pg Koopmans; Rik L de Swart
Journal:  Curr Opin Virol       Date:  2021-06-29       Impact factor: 7.090

10.  Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.

Authors:  Claudia Schulz; Claudia Wylezich; Kerstin Wernike; Magdalena Gründl; Alexandra Dangel; Christine Baechlein; Donata Hoffmann; Susanne Röhrs; Sabrina Hepner; Nikolaus Ackermann; Andreas Sing; Isabelle Pink; Beate Länger; Holger A Volk; Paul Becher; Gerd Sutter; Antonie Neubauer-Juric; Maren von Köckritz-Blickwede; Martin Beer; Asisa Volz
Journal:  Emerg Infect Dis       Date:  2021-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.